Karyotypic characterization of urinary bladder transitional cell carcinomas

Genes Chromosomes and Cancer

Volumn 29, Issue 3, 2000, Pages 256-265

  Fadl Elmula, Imad ^a   Gorunova, Ludmila ^a   Mandahl, Nils ^a   Elfving, Peter ^a   Lundgren, Rolf ^b   Mitelman, Felix ^a   Heim, Sverre ^c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b HELSINGBORG HOSPITAL   (Sweden)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; MALE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; BLADDER NEOPLASMS; CARCINOMA, TRANSITIONAL CELL; CHROMOSOMES, HUMAN; FEMALE; HUMAN; KARYOTYPING; MALE; MIDDLE AGE; NEOPLASM INVASIVENESS; SUPPORT, NON-U.S. GOV'T;

EID: 0033800547     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2264(2000)9999:9999<::AID-GCC1034>3.0.CO;2-O     Document Type: Article

References (39)

1. Loss of Y chromosome: An age-related event or a cytogenetic marker of a malignant clone?
2. Tumor behavior in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology
3. Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization
4. Frequency of homozygous deletion at p16/CDKN2 in primary human turnouts
5. Occupation and cancer of the lower urinary tract
6. Cytogenetic heterogeneity in a second primary radiation-induced bladder carcinoma: Ten karyotypically unrelated clones
7. Cytogenetic monoclonality in multifocal uroepithelial carcinomas: Evidence of intraluminal tumour seeding
8. Cytogenetic analysis of upper urinary tract transitional cell carcinomas
9. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder
10. A possible specific chromosome change in transitional cell carcinoma of the bladder
11. Massive cytogenetic heterogeneity in a pancreatic carcinoma: Fifty-four karyotypically unrelated clones
12. Multiple urlrelated clonal chromosome abnormalities in an in situ squamous cell carcinoma of the skin
13. Superficial bladder cancer: Progression and recurrence
14. Tobacco use, occupation, coffee, various nutrients, and bladder cancer
15. Unrelated clonal chromosomal aberrations in carcinomas of the oral cavity
16. Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer
17. Detection of genetic alterations in bladder tumors by comparative genomic hybridization and cytogenetic analysis
18. Urinary system
19. Homozygous deletion at the 9q32-q33 candidate tumor suppressor locus in primary human bladder cancer
20. Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder
21. Chromosome analysis of 97 primary breast carcinomas: Identification of eight karyotypic subgroups
22. Cancer statistics
23. Treated history of noninvasive grade 1 transitional cell carcinoma: The National Bladder Cancer Group
24. Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC
25. Molecular cytogenetic analysis of superficial urothelial cancer of the bladder
26. Clonal origin of bladder cancer
27. Cancer statistics
28. Late invasive recurrence despite long-term survival for superficial bladder cancer
29. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder turnout cell lines
30. Predictive value of p53 mutations analyzed in bladder washings for progression of high-risk superficial bladder cancer
31. Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization
32. The value of preoperative classification according to the TNM system: A critical examination of category T2 in 96 patients with grade 3 transitional cell bladder carcinoma subjected to preparative irradiation and cystectomy
33. The spectrum of TP53 mutations in bladder carcinoma
34. p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer